Life sciences: Primed for an increase

M&A activity in the life science sector fell in 2024, but several factors, including pent-up demand and the state of companies’ pipelines, point to a strong rebound in dealmaking in 2025.

Feb 19, 2025 - 12:18
 0
Life sciences: Primed for an increase
M&A activity in the life science sector fell in 2024, but several factors, including pent-up demand and the state of companies’ pipelines, point to a strong rebound in dealmaking in 2025.